TFF and NIEHS partner to develop powder formulations for respiratory diseases
Pharmaceutical Technology
MAY 5, 2023
TFF Pharmaceuticals and the National Institute of Environmental Health Sciences (NIEHS) have signed an agreement for the development of dry powder formulations of high molecular weight hyaluronan (HMW-HA) for respiratory diseases.
Let's personalize your content